| HARRIS ASSOCIATES U.S. VALUE EQUITY H-I/A (EUR) | RVI USA VALOR | 4,11% | 34,12% | 32,47% | 168,12% |
| FRANKLIN BIOTECHNOLOGY DISCOVERY A (ACC) USD | RVI BIOTECNOLOGÍA | 81,98% | 91,84% | 63,35% | 168,11% |
| NORDEA 1-ASIA EX JAPAN EQUITY FUND AP-EUR | RVI ASIA EX-JAPÓN CRECIMIENTO | 56,59% | 65,42% | 33,41% | 168,11% |
| BARINGS GLOBAL EMERGING MARKETS FUND A USD CAP | RVI EMERGENTES | 59,63% | 81,07% | 57,18% | 168,10% |
| JPM GLOBAL NATURAL RESOURCES D (ACC) USD | RVI MATERIAS PRIMAS | 43,23% | 51,85% | 79,27% | 168,09% |
| MFS MERIDIAN U.S. CONCENTRATED GROWTH FUND C1-USD | RVI USA CRECIMIENTO | 6,82% | 20,42% | 25,30% | 168,08% |
| ROBECO BP US SELECT OPPORTUNITIES EQUITIES F USD | RVI USA SMALL/MID CAP | 19,61% | 43,69% | 56,86% | 168,07% |
| SCHRODER ISF EMERGING MARKETS B ACC USD | RVI EMERGENTES | 64,81% | 89,20% | 45,05% | 168,05% |
| SCHRODER ISF EUROPEAN VALUE I ACC EUR | RVI EUROPA VALOR | 24,73% | 62,34% | 90,36% | 168,02% |
| FRANKLIN BIOTECHNOLOGY DISCOVERY A (ACC) HKD | RVI BIOTECNOLOGÍA | 81,95% | 91,78% | 63,36% | 167,97% |
| FIDELITY FUNDS-EMERGING ASIA A-ACC-USD | RVI ASIA EX-JAPÓN | 51,17% | 71,75% | 57,13% | 167,95% |
| FRANKLIN BIOTECHNOLOGY DISCOVERY A (ACC) SGD | RVI BIOTECNOLOGÍA | 82,09% | 91,64% | 63,12% | 167,92% |
| TEMPLETON ASIAN GROWTH W (ACC) GBP | RVI ASIA EX-JAPÓN CRECIMIENTO | 64,52% | 88,74% | 45,85% | 167,89% |
| BGF ASIAN DRAGON I2 EUR | RVI ASIA EX-JAPÓN | 47,59% | 66,06% | 43,72% | 167,87% |
| BLACKROCK EUROPEAN OPPORTUNITIES EXTENSION A2 EUR | RVI EUROPA | 9,17% | 32,09% | 31,29% | 167,87% |
| BGF SYSTEMATIC GLOBAL SMALLCAP A2 EUR | RVI GLOBAL SMALL/MID CAP | 33,39% | 61,32% | 59,58% | 167,83% |
| AXA WORLD FUNDS-EVOLVING TRENDS I CAP EUR | RVI GLOBAL | 12,44% | 31,37% | 22,31% | 167,82% |
| GOLDMAN SACHS EUROZONE EQUITY I CAP EUR | RV EURO | 24,52% | 62,55% | 67,21% | 167,76% |
| ROBECO BP US LARGE CAP EQUITIES FH EUR | RVI USA | 29,17% | 66,28% | 61,47% | 167,69% |
| ROBECO EMERGING MARKETS EQUITIES M EUR | RVI EMERGENTES | 51,88% | 77,40% | 51,84% | 167,67% |
